Historical record - last NADAC publication: 5/23/2013
Product Information
MECLOFENAMATE 100 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $4.1903 per EA under NDC 00378300001. Its NADAC has been published 29 times since Nov 28, 2013.
Strength
100 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378300001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
5/23/2013
Active Ingredients
MECLOFENAMATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA071081On Market Since
9/3/1986
Price Statistics
The NADAC for MECLOFENAMATE 100 MG CAPSULE has been published 29 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1903 per EA |
|---|---|
| All-time high | $4.1903 (Jun 11, 2014) |
| All-time low | $4.1903 (Nov 28, 2013) |
| Median price | $4.1903 |
| Average price | $4.1903 |
| Largest weekly change | 0.0% (Dec 5, 2013) |
| Weeks tracked | 29 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the meclofenamate sodium market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MECLOFENAMATE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MECLOFENAMATE 100 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $4.1903 per EA (NDC 00378300001), effective Jun 11, 2014.
How has the price of MECLOFENAMATE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MECLOFENAMATE 100 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 29 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MECLOFENAMATE 100 MG CAPSULE?
Since Nov 28, 2013, the NADAC for MECLOFENAMATE 100 MG CAPSULE has ranged from a low of $4.1903 (Nov 28, 2013) to a high of $4.1903 (Jun 11, 2014), with a median of $4.1903 per EA.
Are there cheaper alternatives to MECLOFENAMATE 100 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MECLOFENAMATE 100 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures MECLOFENAMATE 100 MG CAPSULE?
MECLOFENAMATE 100 MG CAPSULE (NDC 00378300001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification